Key Facts
Closed Loop Medicine is a healthcare company developing drug+SaMD combination products, transforming drug effectiveness by providing every drug with its real time digital companion. To date the company has raised a total of over £22 million (c. £$30 million) since founding. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. Closed Loop Medicine is developing a new product class, a combinational therapy that binds drug therapy with digital therapy to personalise care for patients. Whilst the company is currently focused on products for hypertension and sleep, it aims to further develop its pipeline with additional single-prescription combination products for a wide portfolio of chronic diseases, ensuring that both patient and clinician are at the centre of its products and solutions.
Successes in UK/NHS
Key clinical partnership with Queen Mary University London and Bart’s Health for an interventional clinical trial as well as existing engagements with UCLP and Eastern AHSN. Professor David Collier is the lead investigator for the clinical trial. Contact details available on request.Company details
Solutions
Delivering advanced patient care
Specialism
Digitally-enabled out of hospital care
Company details

Want to connect with this innovator?
Make an enquiryWebsite
www.closedloopmedicine.comDetails
View on Companies HouseMarkets already exporting to
None
Desired Markets
USA, EU, India, Asia Pac
Desired customer types
Pharma, Generics and Healthcare Providers